Zydelig (idelalisib) - Gilead
bryostatin 1 (NSC 339555) - Neurotrope
Arzerra (ofatumumab) - Novartis, Genmab
Gazyva (obinutuzumab) - Roche, Biogen
Rituxan (rituximab) - Biogen, Zenyaku Kogyo, Roche
Imbruvica (ibrutinib) - AbbVie, J&J
Venclexta (venetoclax) - Roche, AbbVie
Calquence (acalabrutinib) - AstraZeneca
Copiktra (duvelisib) - Verastem
http://www.ncbi.nlm.nih.gov/pubmed/32482755
 
Jun 3, 2020
 
Prev Next